An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates (Q92040902)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

26 April 2020

title

An FDA oncology analysis of toxicities associated with PBD-containing antibody-drug conjugates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

26 April 2020

author name string

Haleh Saber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

26 April 2020

Natalie Simpson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

26 April 2020

Tiffany K Ricks

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

26 April 2020

John K Leighton

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

26 April 2020

publication date

17 July 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

Regulatory Toxicology and Pharmacology

26 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

26 April 2020

volume

107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

26 April 2020

page(s)

104429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

Strategies and challenges for the next generation of antibody-drug conjugates

26 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

TSPO: An Evolutionarily Conserved Protein with Elusive Functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Antibody Drug Conjugates: Preclinical Considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Effects of different doses and schedules of diazepam treatment on lymphocyte parameters in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Recent Developments in ADC Technology: Preclinical Studies Signal Future Clinical Trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Differential effects of alprazolam and clonazepam on the immune system and blood vessels of non-stressed and stressed adult male albino rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

The development of pyrrolobenzodiazepines as antitumour agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Phase I study of sequence-selective minor groove DNA binding agent SJG-136 in patients with advanced solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Regulation of Translocator Protein 18 kDa (TSPO) Expression in Rat and Human Male Germ Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Antibody Drug Conjugates: Nonclinical Safety Considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Fractionated Dosing Improves Preclinical Therapeutic Index of Pyrrolobenzodiazepine-Containing Antibody Drug Conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Antibody Drug Conjugates for Cancer Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Phase I pharmacokinetic and pharmacodynamic study of SJG-136, a novel DNA sequence selective minor groove cross-linking agent, in advanced solid tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Antibody-Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

Effect of benzodiazepine derivatives: I. Augmentation of T cell-dependent antibody response by diazepam in mouse spleen cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YRTPH.2019.104429

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YRTPH.2019.104429

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31325532 AND SRC:MED&resulttype=core&format=json

26 April 2020

1 reference